| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CI-976 | CTRPv2 | pan-cancer | AAC | -0.036 | 0.4 |
| mRNA | PDMP | CTRPv2 | pan-cancer | AAC | -0.035 | 0.4 |
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | AC55649 | CTRPv2 | pan-cancer | AAC | -0.036 | 0.4 |
| mRNA | BRD-K51490254 | CTRPv2 | pan-cancer | AAC | -0.035 | 0.4 |
| mRNA | 16-beta-bromoandrosterone | CTRPv2 | pan-cancer | AAC | -0.035 | 0.4 |
| mRNA | PHA-665752 | GDSC1000 | pan-cancer | AAC | -0.048 | 0.4 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.055 | 0.4 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | -0.044 | 0.4 |